Your browser doesn't support javascript.
loading
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
Tzoumpa, Sofia; Ingen-Housz-Oro, Saskia; de Masson, Adèle; Pham-Ledard, Anne; El Aarbaoui, Tarik; Dereure, Olivier; Quereux, Gaëlle; Faiz, Sarah; de Vicq de Cumptich, Marine; Ram-Wolff, Caroline; Janela-Lapert, Raphaël; Guenova, Emmanuella; Lheure, Coralie; Le Corre, Yannick; Adamski, Henri; Blanchard, Maël; Bonnet, Nathalie; Amatore, Florent; Grange, Florent; Troin, Laura; Bagot, Martine; Beylot-Barry, Marie.
Afiliación
  • Tzoumpa S; Department of Dermatology, Henri-Mondor University Hospital, AP-HP, Créteil, France.
  • Ingen-Housz-Oro S; Department of Dermatology, Henri-Mondor University Hospital, AP-HP, Créteil, France.
  • de Masson A; Paris Est Créteil University, EpiDermE, Créteil, France.
  • Pham-Ledard A; French Cutaneous Lymphomas Study Group (GFELC), France.
  • El Aarbaoui T; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Dereure O; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Quereux G; Paris Est Créteil University, EpiDermE, Créteil, France.
  • Faiz S; French Cutaneous Lymphomas Study Group (GFELC), France.
  • de Vicq de Cumptich M; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Ram-Wolff C; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Janela-Lapert R; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Guenova E; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Lheure C; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Le Corre Y; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Adamski H; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Blanchard M; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Bonnet N; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Amatore F; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Grange F; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Troin L; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Bagot M; French Cutaneous Lymphomas Study Group (GFELC), France.
  • Beylot-Barry M; French Cutaneous Lymphomas Study Group (GFELC), France.
Br J Dermatol ; 191(1): 143-144, 2024 Jun 20.
Article en En | MEDLINE | ID: mdl-38660811

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Síndrome de Sézary / Progresión de la Enfermedad / Anticuerpos Monoclonales Humanizados Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Síndrome de Sézary / Progresión de la Enfermedad / Anticuerpos Monoclonales Humanizados Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido